Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$1.0 - $1.39 $3,001 - $4,171
3,001 Added 10.71%
31,011 $34,000
Q3 2023

Nov 03, 2023

BUY
$1.22 - $4.83 $3,416 - $13,524
2,800 Added 11.11%
28,010 $34,000
Q2 2023

Aug 09, 2023

BUY
$2.95 - $4.44 $20,647 - $31,075
6,999 Added 38.43%
25,210 $98,000
Q1 2023

May 10, 2023

BUY
$2.94 - $4.18 $1,181 - $1,680
402 Added 2.26%
18,211 $59,000
Q4 2022

Feb 02, 2023

BUY
$2.73 - $3.7 $7,264 - $9,845
2,661 Added 17.57%
17,809 $51,000
Q3 2022

Nov 01, 2022

SELL
$0.48 - $3.48 $1,277 - $9,260
-2,661 Reduced 14.94%
15,148 $42,000
Q2 2022

Aug 12, 2022

BUY
$2.22 - $4.54 $6,660 - $13,620
3,000 Added 20.26%
17,809 $39,000
Q1 2022

May 05, 2022

BUY
$3.58 - $4.98 $53,016 - $73,748
14,809 New
14,809 $60,000
Q4 2020

Jan 29, 2021

SELL
$8.21 - $18.59 $148,921 - $337,204
-18,139 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$11.33 - $19.81 $205,514 - $359,333
18,139 New
18,139 $539,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.57B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Summit X, LLC Portfolio

Follow Summit X, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.